Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 5;12(11):1802-1809.
doi: 10.1021/acsmedchemlett.1c00416. eCollection 2021 Nov 11.

Piperazinyl Bicyclic Derivatives as Selective Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels

Affiliations

Piperazinyl Bicyclic Derivatives as Selective Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels

Ariadna Fernández et al. ACS Med Chem Lett. .

Abstract

The synthesis and pharmacological activities of a new series of piperazinyl quinazolin-4-(3H)-one derivatives acting toward the α2δ-1 subunit of voltage-gated calcium channels (Cavα2δ-1) are reported. Different positions of a micromolar HTS hit were explored, and best activities were obtained for compounds containing a small alkyl group in position 3 of the quinazolin-4-(3H)-one scaffold and a 3-methyl-piperazin-1-yl- or 3,5-dimethyl-piperazin-1-yl-butyl group in position 2. The activity was shown to reside in the R enantiomer of the chain in position 2, and several eutomers reached single digit nanomolar affinities. Final modification of the central scaffold to reduce lipophilicity provided the pyrido[4,3-d]pyrimidin-4(3H)-one 16RR, which showed high selectivity for Cavα2δ-1 versus Cavα2δ-2, probably linked to its improved analgesic efficacy-safety ratio in mice over pregabalin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Structures of pregabalin (1) and HTS hit 2 and summary of SAR study leading to 16RR.
Scheme 1
Scheme 1
Reagents and conditions: (a) DMF, TEA, HATU, 0 °C to rt, overnight; (b) DCM, TEA, 0 °C to rt, overnight; (c) I2, HMDS, DCM, 0 °C to rt, overnight; (d) Br2, AcOH, NaOAc, 50 °C, 3 h; (e) ACN, TEA, KI, 90 °C, overnight.
Scheme 2
Scheme 2
Reagents and conditions: (a) H2SO4, NaNO2, 0 °C to rt, 16 h; (b) HATU, TEA, DCM, rt, 16 h; (c) I2, HMDS, DCM, 50 °C, 16 h; (d) TBAF, THF, 0 °C, 30 min; (e) 2,6-lutidine, Tf2O, DCM, −78 °C, 2 h; (f) DMF/DCM, −78 °C to rt, 4 h (; (g) MsCl, DIPEA, DCM, −78 °C, 5 min; (h) ACN, 80 °C, 24 h.
Figure 2
Figure 2
(A) Effects of pregabalin (1) and 16RR on mechanical hypersensitivity (allodynia) induced by intraplantar injection of capsaicin (1 μg) to mouse hind paw. The results represent the percentage reduction in capsaicin-induced mechanical hypersensitivity. (B) Effect of 1 and 16RR on motor coordination using the rotarod test. The results represent the latencies to fall-down from the elevated rotating drum. Rotarod latencies were measured at 30, 120, and 180 min after administration of vehicle or compounds 1 and 16RR at 20 mg/kg ip.

Similar articles

Cited by

References

    1. Zamponi G. W.; Striessnig J.; Koschak A.; Dolphin A. C. The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential. Pharmacol. Rev. 2015, 67, 821–870. 10.1124/pr.114.009654. - DOI - PMC - PubMed
    1. Perret D.; Luo Z. D. Targeting voltage-gated calcium channels for neuropathic pain management. Neurotherapeutics 2009, 6, 679–692. 10.1016/j.nurt.2009.07.006. - DOI - PMC - PubMed
    1. Derry S.; Cording M.; Wiffen P. J.; Law S.; Phillips T.; Moore R. A. Pregabalin for pain in fibromyalgia in adults. Cochrane Database Syst. Rev. 2016, 29, CD011790.10.1002/14651858.CD011790.pub2. - DOI - PMC - PubMed
    1. Taylor C. P.; Angelotti T.; Fauman E. Pharmacology and mechanism of action of pregabalin: The calcium channel alpha2-selta subunit as a target for antiepileptic drug discovery. Epilepsy Res. 2007, 73, 137–150. 10.1016/j.eplepsyres.2006.09.008. - DOI - PubMed
    1. Faulkner M. A. Use of α2δ ligands for restless legs syndrome/Willis Ekbom Disease. CNS Drugs 2018, 32, 149–159. 10.1007/s40263-018-0502-z. - DOI - PubMed

LinkOut - more resources